| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Receptor Signaling Is Essential for the Initiation, Acceleration, and Destruction of Autoimmune Kidney Disease in MRL-Faslpr Mice1
Laboratory of Molecular Autoimmune Disease, Renal Division, Brigham and Women’s Hospital, Boston, MA 02115
CSF-1 and TNF-
in the kidney of
MRL-Faslpr mice are proximal events
that precede and promote autoimmune lupus nephritis, while apoptosis of
renal parenchymal cells is a feature of advanced human lupus nephritis.
In the MRL-Faslpr kidney,
infiltrating T cells that secrete IFN-
are a hallmark of disease. To
examine the impact of IFN- on renal injury in
MRL-Faslpr mice, we constructed a
IFN-R-deficient strain. In
MRL-Faslpr mice lacking IFN-R,
circulating and intrarenal CSF-1 were absent, TNF- was markedly
reduced, survival was extended, lymphadenopathy and splenomegaly were
prevented, and the kidneys remained protected from destruction.
Mesangial cells (MC) that were signaled through the IFN-R induced
CSF-1 and TNF- in MRL-Faslpr
mice. We detected a large number of apoptotic renal parenchymal cells
in advanced nephritis and determined that signaling via the IFN-R
induces apoptosis of tubular epithelial cells (TEC), but not MC. By
comparison, TNF- induces apoptosis in MC, but not TEC, of the
MRL-Faslpr strain. Thus, IFN- is
directly and indirectly responsible for apoptosis of TEC and MC in
MRL-Faslpr mice, respectively. In
conclusion, IFN-R signaling is essential for the initiation (CSF-1),
acceleration (CSF-1 and TNF-), and apoptotic destruction of renal
parenchymal cells in MRL-Faslpr
autoimmune kidney disease.
This article has been cited by other articles:
|
|
 |
|
  J. M. Odegard, L. D. DiPlacido, L. Greenwald, M. Kashgarian, D. H. Kono, C. Dong, R. A. Flavell, and J. Craft ICOS Controls Effector Function but Not Trafficking Receptor Expression of Kidney-Infiltrating Effector T Cells in Murine Lupus J. Immunol., April 1, 2009; 182(7): 4076 - 4084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-M. Deng and G. C. Tsokos Cholera Toxin B Accelerates Disease Progression in Lupus-Prone Mice by Promoting Lipid Raft Aggregation J. Immunol., September 15, 2008; 181(6): 4019 - 4026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Harigai, M. Kawamoto, M. Hara, T. Kubota, N. Kamatani, and N. Miyasaka Excessive Production of IFN-{gamma} in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B J. Immunol., August 1, 2008; 181(3): 2211 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Doodes, Y. Cao, K. M. Hamel, Y. Wang, B. Farkas, Y. Iwakura, and A. Finnegan Development of Proteoglycan-Induced Arthritis Is Independent of IL-17 J. Immunol., July 1, 2008; 181(1): 329 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Menke, G. C. Zeller, E. Kikawada, T. K. Means, X. R. Huang, H. Y. Lan, B. Lu, J. Farber, A. D. Luster, and V. R. Kelley CXCL9, but not CXCL10, Promotes CXCR3-Dependent Immune-Mediated Kidney Disease J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1177 - 1189. [Full Text] [PDF]
|
|
|
|
|
|
U. Sela, M. Dayan, R. Hershkoviz, O. Lider, and E. Mozes A Peptide That Ameliorates Lupus Up-Regulates the Diminished Expression of Early Growth Response Factors 2 and 3 J. Immunol., February 1, 2008; 180(3): 1584 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Martinez-Lostao, J. Ordi-Ros, E. Balada, A. Segarra-Medrano, J. Majo-Masferrer, M. Labrador-Horrillo, and M. Vilardell-Tarres Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis Lupus, July 1, 2007; 16(7): 483 - 488. [Abstract] [PDF]
|
|
|
|
|
|
E. Ko, Y. Lee, N. Park, C. Cho, Y.-N. Yim, J. Kim, Y.S. Kim, D. Kim, M.-K. Shin, M.-C. Hong, et al. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model Lupus, May 1, 2007; 16(5): 335 - 341. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Bobe, D. Bonardelle, K. Benihoud, P. Opolon, and M. K. Chelbi-Alix Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice Blood, December 15, 2006; 108(13): 3967 - 3975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Neumann, T. Tschernig, D. Popa, A. Schmiedl, G. P. de Lema, K. Resch, and M. U. Martin Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms Int. Immunol., December 1, 2006; 18(12): 1779 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Zeller, J. Hirahashi, A. Schwarting, A. H. Sharpe, and V. R. Kelley Inducible Co-Stimulator Null MRL-Faslpr Mice: Uncoupling of Autoantibodies and T Cell Responses in Lupus J. Am. Soc. Nephrol., January 1, 2006; 17(1): 122 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shimizu, N. Sugiyama, K. Masutani, A. Sadanaga, Y. Miyazaki, Y. Inoue, M. Akahoshi, R. Katafuchi, H. Hirakata, M. Harada, et al. Membranous Glomerulonephritis Development with Th2-Type Immune Deviations in MRL/lpr Mice Deficient for IL-27 Receptor (WSX-1) J. Immunol., December 1, 2005; 175(11): 7185 - 7192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. de Lema, H. Maier, T. J. Franz, M. Escribese, S. Chilla, S. Segerer, N. Camarasa, H. Schmid, B. Banas, S. Kalaydjiev, et al. Chemokine Receptor Ccr2 Deficiency Reduces Renal Disease and Prolongs Survival in MRL/lpr Lupus-Prone Mice J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3592 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bonardelle, K. Benihoud, N. Kiger, and P. Bobe B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice J. Leukoc. Biol., November 1, 2005; 78(5): 1052 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kitching More Targeted Treatments for Lupus Nephritis: Is the Future (Nearly) Here? J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3146 - 3148. [Full Text] [PDF]
|
|
|
|
|
|
A. Schwarting, K. Paul, S. Tschirner, J. Menke, T. Hansen, W. Brenner, V. R. Kelley, M. Relle, and P. R. Galle Interferon-{beta}: A Therapeutic for Autoimmune Lupus in MRL-Faslpr Mice J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3264 - 3272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Aringer and J S Smolen Cytokine expression in lupus kidneys Lupus, January 1, 2005; 14(1): 13 - 18. [Abstract] [PDF]
|
|
|
|
|
|
X. K. Zhang, S. Gallant, I. Molano, O. M. Moussa, P. Ruiz, D. D. Spyropoulos, D. K. Watson, and G. Gilkeson Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/lpr Mice J. Immunol., November 15, 2004; 173(10): 6481 - 6489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kinoshita, T. Yamagata, Y. Nozaki, M. Sugiyama, S. Ikoma, M. Funauchi, and A. Kanamaru Blockade of IL-18 Receptor Signaling Delays the Onset of Autoimmune Disease in MRL-Faslpr Mice J. Immunol., October 15, 2004; 173(8): 5312 - 5318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Lenda, E. R. Stanley, and V. R. Kelley Negative Role of Colony-Stimulating Factor-1 in Macrophage, T Cell, and B Cell Mediated Autoimmune Disease in MRL-Faslpr Mice J. Immunol., October 1, 2004; 173(7): 4744 - 4754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Reilly, N. Mishra, J. M. Miller, D. Joshi, P. Ruiz, V. M. Richon, P. A. Marks, and G. S. Gilkeson Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid J. Immunol., September 15, 2004; 173(6): 4171 - 4178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Hron and S. L. Peng Type I IFN Protects Against Murine Lupus J. Immunol., August 1, 2004; 173(3): 2134 - 2142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kitching, A. L. Turner, T. Semple, M. Li, K. L. Edgtton, G. R. Wilson, J. R. Timoshanko, B. G. Hudson, and S. R. Holdsworth Experimental Autoimmune Anti-Glomerular Basement Membrane Glomerulonephritis: A Protective Role for IFN-{gamma} J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1764 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chen, F. Aosai, K. Norose, H.-S. Mun, H. Ishikura, S. Hirose, L.-X. Piao, H. Fang, and A. Yano Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice Int. Immunol., July 1, 2004; 16(7): 937 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Choudhury A Linear Signal Transduction Pathway Involving Phosphatidylinositol 3-Kinase, Protein Kinase C{epsilon}, and MAPK in Mesangial Cells Regulates Interferon-{gamma}-induced STAT1{alpha} Transcriptional Activation J. Biol. Chem., June 25, 2004; 279(26): 27399 - 27409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bossu, D. Neumann, E. Del Giudice, A. Ciaramella, I. Gloaguen, G. Fantuzzi, C. A. Dinarello, E. Di Carlo, P. Musiani, P. L. Meroni, et al. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease PNAS, November 25, 2003; 100(24): 14181 - 14186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-S. Uhm, K. Na, G.-W. Song, S.-S. Jung, T. Lee, M.-H. Park, and D.-H. Yoo Cytokine balance in kidney tissue from lupus nephritis patients Rheumatology, August 1, 2003; 42(8): 935 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kinoshita, B.-S. Yoo, Y. Nozaki, M. Sugiyama, S. Ikoma, M. Ohno, M. Funauchi, and A. Kanamaru Retinoic Acid Reduces Autoimmune Renal Injury and Increases Survival in NZB/W F1 Mice J. Immunol., June 1, 2003; 170(11): 5793 - 5798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kikawada, D. M. Lenda, and V. R. Kelley IL-12 Deficiency in MRL-Faslpr Mice Delays Nephritis and Intrarenal IFN-{gamma} Expression, and Diminishes Systemic Pathology J. Immunol., April 1, 2003; 170(7): 3915 - 3925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-L. Santiago-Raber, R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice J. Exp. Med., March 17, 2003; 197(6): 777 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Carvalho-Pinto, M. I. Garcia, M. Mellado, J. M. Rodriguez-Frade, J. Martin-Caballero, J. Flores, C. Martinez-A, and D. Balomenos Autocrine Production of IFN-{gamma} by Macrophages Controls Their Recruitment to Kidney and the Development of Glomerulonephritis in MRL/lpr Mice J. Immunol., July 15, 2002; 169(2): 1058 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Timoshanko, S. R. Holdsworth, A. R. Kitching, and P. G. Tipping IFN-{gamma} Production by Intrinsic Renal Cells and Bone Marrow-Derived Cells Is Required for Full Expression of Crescentic Glomerulonephritis in Mice J. Immunol., April 15, 2002; 168(8): 4135 - 4141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Jolly, A. Muthukumar, C. P. R. Avula, D. Troyer, and G. Fernandes Life Span Is Prolonged in Food-Restricted Autoimmune-Prone (NZB NZW)F(1) Mice Fed a Diet Enriched with (n-3) Fatty Acids J. Nutr., October 1, 2001; 131(10): 2753 - 2760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. D. LEMA, H. MAIER, E. NIETO, V. VIELHAUER, B. LUCKOW, F. MAMPASO, and D. SCHLONDORFF Chemokine Expression Precedes Inflammatory Cell Infiltration and Chemokine Receptor and Cytokine Expression during the Initiation of Murine Lupus Nephritis J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1369 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Halloran, L. W. Miller, J. Urmson, V. Ramassar, L.-F. Zhu, N. M. Kneteman, K. Solez, and M. Afrouzian IFN-{{gamma}} Alters the Pathology of Graft Rejection: Protection from Early Necrosis J. Immunol., June 15, 2001; 166(12): 7072 - 7081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Neumann, E. Del Giudice, A. Ciaramella, D. Boraschi, and P. Bossu Lymphocytes from Autoimmune MRL lpr/lpr Mice Are Hyperresponsive to IL-18 and Overexpress the IL-18 Receptor Accessory Chain J. Immunol., March 15, 2001; 166(6): 3757 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Matthys, K. Vermeire, H. Heremans, and A. Billiau The protective effect of IFN-{gamma} in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis J. Leukoc. Biol., October 1, 2000; 68(4): 447 - 454. [Abstract] [Full Text]
|
|
|
|
|
|
M. Satoh, J. P. Weintraub, H. Yoshida, V. M. Shaheen, H. B. Richards, M. Shaw, and W. H. Reeves Fas and Fas Ligand Mutations Inhibit Autoantibody Production in Pristane-Induced Lupus J. Immunol., July 15, 2000; 165(2): 1036 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kinoshita, G. Tesch, A. Schwarting, R. Maron, A. H. Sharpe, and V. R. Kelley Costimulation by B7-1 and B7-2 Is Required for Autoimmune Disease in MRL-Faslpr Mice J. Immunol., June 1, 2000; 164(11): 6046 - 6056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Reilly, J. C. Oates, J. A. Cook, J. D. Morrow, P. V. Halushka, and G. S. Gilkeson Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-{gamma} Agonists J. Immunol., February 1, 2000; 164(3): 1498 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Tesch, S. Maifert, A. Schwarting, B. J. Rollins, and V. R. Kelley Monocyte Chemoattractant Protein 1-dependent Leukocytic Infiltrates Are Responsible for Autoimmune Disease in MRL-Faslpr Mice J. Exp. Med., December 20, 1999; 190(12): 1813 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schwarting, G. Tesch, K. Kinoshita, R. Maron, H. L. Weiner, and V. R. Kelley IL-12 Drives IFN-{gamma}-Dependent Autoimmune Kidney Disease in MRL-Faslpr Mice J. Immunol., December 15, 1999; 163(12): 6884 - 6891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kuroiwa, E. G. Lee, C. L. Danning, G. G. Illei, I. B. McInnes, and D. T. Boumpas CD40 Ligand-Activated Human Monocytes Amplify Glomerular Inflammatory Responses Through Soluble and Cell-to-Cell Contact-Dependent Mechanisims J. Immunol., August 15, 1999; 163(4): 2168 - 2175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Ring, Z. Dai, S. Saleem, F. K. Baddoura, and F. G. Lakkis Increased Susceptibility to Immunologically Mediated Glomerulonephritis in IFN-{gamma}-Deficient Mice J. Immunol., August 15, 1999; 163(4): 2243 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A N Theofilopoulos Effector and predisposing genes in murine lupus Lupus, November 1, 1998; 7(9): 575 - 584. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
